Specialty medicines have become a large portion of healthcare spend, consuming over $200 billion of a total estimated $480 billion in pharmacy spend per year and have become an important component for payers to understand, measure, and manage. This study provides claim cost benchmarks to illustrate the magnitude and distribution of specialty medication costs adjudicated under both the pharmacy and medical benefit for a commercially insured population.